Convergence Investment Partners LLC Raises Holdings in DaVita Inc. (NYSE:DVA)

Convergence Investment Partners LLC lifted its holdings in DaVita Inc. (NYSE:DVA - Free Report) by 33.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 11,389 shares of the company's stock after acquiring an additional 2,836 shares during the period. Convergence Investment Partners LLC's holdings in DaVita were worth $1,703,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Franklin Resources Inc. lifted its stake in shares of DaVita by 134.6% in the 3rd quarter. Franklin Resources Inc. now owns 54,901 shares of the company's stock valued at $8,885,000 after purchasing an additional 31,502 shares during the last quarter. FMR LLC lifted its position in DaVita by 659.9% in the third quarter. FMR LLC now owns 177,406 shares of the company's stock worth $29,082,000 after buying an additional 154,061 shares during the last quarter. Atom Investors LP purchased a new position in DaVita during the third quarter worth $4,094,000. Assenagon Asset Management S.A. increased its position in DaVita by 201.7% during the fourth quarter. Assenagon Asset Management S.A. now owns 74,617 shares of the company's stock valued at $11,159,000 after acquiring an additional 49,885 shares during the last quarter. Finally, Neo Ivy Capital Management bought a new position in DaVita during the third quarter valued at $726,000. Hedge funds and other institutional investors own 90.12% of the company's stock.

Analyst Upgrades and Downgrades

Separately, Barclays lifted their price target on shares of DaVita from $164.00 to $169.00 and gave the stock an "equal weight" rating in a research note on Tuesday. One analyst has rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the company's stock. According to data from MarketBeat, DaVita has an average rating of "Hold" and an average target price of $162.80.

DaVita Trading Down 2.5 %

Shares of NYSE:DVA traded down $3.59 on Friday, hitting $142.33. 1,605,084 shares of the company's stock were exchanged, compared to its average volume of 845,867. The stock has a market capitalization of $11.39 billion, a price-to-earnings ratio of 13.25, a price-to-earnings-growth ratio of 1.14 and a beta of 0.94. DaVita Inc. has a 12 month low of $120.78 and a 12 month high of $179.60. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.26 and a quick ratio of 1.21. The business's 50 day simple moving average is $161.24 and its two-hundred day simple moving average is $157.81.

DaVita (NYSE:DVA - Get Free Report) last announced its quarterly earnings data on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, beating analysts' consensus estimates of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. Analysts anticipate that DaVita Inc. will post 10.76 EPS for the current fiscal year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.